RPL30P11

Across TCGA pan-cancer cohorts, RPL30P11 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPL30P11 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL30P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL30P11 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.

KIRC, COAD, and LUAD are the cancer types where RPL30P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	IV	0.178	0.435	<.001	109	view →
COAD	DFS	Tertile	All	0.570	0.727	<.001	79	view →
LUAD	DFS	Median	All	0.831	0.699	.003	78	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	48	view →
MESO	DFS	Tertile	All	0.393	0.201	.005	34	view →
KICH	DFS	Tertile	All	0.647	0.953	.026	23	view →
CHOL	DFS	Tertile	II,III,IV	1.000	0.133	.010	15	view →
UVM	OS	Tertile	II,III,IV	0.783	0.402	.010	13	view →
LUSC	OS	Tertile	IV	0.057	0.786	.038	12	view →
LGG	OS	Tertile	All	0.853	0.924	.003	11	view →
THCA	DFS	Quartile	II,III,IV	0.898	0.977	.018	10	view →
LIHC	DFS	Quartile	All	0.343	0.555	.012	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPL30P11–KIRC (DFS)

Open the KIRC breakdown →